ESTEVE PHARMACEUTICALS, S.A.

About ESTEVE PHARMACEUTICALS, S.A.

ESTEVE is an integrated international group that pursues excellence in the pharmaceutical-chemical industry. Founded in 1929, our staff is around 2.500 people worldwide with a turnover around EURO 800 Million, headquartered in Barcelona (Spain). Finished Dosage Form manufacturing site is regularly inspected by US FDA, European Agencies, and other Agencies of the rest of the world. ESTEVE's fields: NCE's, Generics and OTC. We offer leading-edge capabilities in the development and manufacturing of complex formulations, mainly pellets and other solid oral forms, with customers on a world wide basis.

  • ES
  • 2015
    On CPHI since
Contact info

Products from ESTEVE PHARMACEUTICALS, S.A. (3)

  • Omeprazole Second Generation

    Product Omeprazole Second Generation

    Therapeutic Category: Gastric Proton Pump Inhibitor Strength: 10, 20, and 40 mg Pharmaceutical Form: Capsules EU CTD Brand name: Losec, Prilosec
  • Duloxetine HCI

    Product Duloxetine HCI

    Therapeutic Category: Antidepressant, Neuropatic pain, Urinary incontinenceStrength: 20, 30, 40, 45 and 60 mg Pharmaceutical Form: Capsules EU and US CTD Brand name: Cymbalta, Yentreve
  • Esomeprazole

    Product Esomeprazole

    Therapeutic Category: Gastric Proton Pump Inhibitor Strength: 20 and 40 mg Pharmaceutical Form: Tablets EU CTD Brand name: Nexium